Caution is advised when consuming alcohol with Lopimune 50 mg/200 mg Capsule. Please consult your doctor.
Lopimune 50 mg/200 mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Lopimune 50 mg/200 mg Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Lopimune 50 mg/200 mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Lopimune 50 mg/200 mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Lopimune 50 mg/200 mg Capsule may not be needed in these patients. Please consult your doctor.
Lopimune 50 mg/200 mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Lopimune 50 mg/200 mg Capsule may be needed. Please consult your doctor.
If you miss a dose of Lopimune 50 mg/200 mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mylan Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Veritaz Healthcare Ltd || ₹14.5/tablet (25% cheaper)